Tumor necrosis factor-α in heart failure: an updated review

SM Schumacher, SV Naga Prasad - Current cardiology reports, 2018 - Springer
Abstract Purpose of the Review Proinflammatory cytokines are consistently elevated in
congestive heart failure. In the current review, we provide an overview on the current …

Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL

E Harper, H Forde, C Davenport, KD Rochfort… - Vascular …, 2016 - Elsevier
Vascular calcification (VC), a disorder that causes blood vessel hardening and dysfunction,
is a significant risk factor for type-2 diabetes mellitus (T2DM), which invariably manifests …

Bone in heart failure

G Loncar, N Cvetinovic, M Lainscak… - Journal of Cachexia …, 2020 - Wiley Online Library
There is an increasing interest in osteoporosis and reduced bone mineral density affecting
not only post‐menopausal women but also men, particularly with coexisting chronic …

Bone status in men with heart failure: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure

G Loncar, T Garfias‐Veitl, M Valentova… - European Journal of …, 2023 - Wiley Online Library
Aim To assess bone status expressed as hip bone mineral density (BMD) in men with heart
failure (HF). Methods and results A total of 141 male patients with HF underwent dual energy …

Association of adiponectin with peripheral muscle status in elderly patients with heart failure

G Loncar, B Bozic, S Von Haehling, HD Düngen… - European journal of …, 2013 - Elsevier
Background Reduced peripheral muscle mass was demonstrated in patients with chronic
heart failure (HF). Adipokines may have potent metabolic effects on skeletal muscle. The …

Adiponectin in metabolic bone disease

I Kanazawa - Current medicinal chemistry, 2012 - ingentaconnect.com
Adiponectin has attracted widespread attention because of its pivotal role in glucose
metabolism and energy homeostasis. Adiponectin and its receptor are shown to be …

Angiotensin II stimulation of cardiac hypertrophy and functional decompensation in osteoprotegerin-deficient mice

T Tsuruda, Y Sekita-Hatakeyama, Y Hao… - …, 2016 - Am Heart Assoc
Circulating and myocardial expressions of receptor activator of nuclear factor-κb ligand and
osteoprotegerin are activated in heart failure; however, it remains to be determined their …

Does the OPG/RANKL system contribute to the bone-vascular axis in chronic kidney disease? A systematic review

B Znorko, E Oksztulska-Kolanek, M Michałowska… - Advances in Medical …, 2017 - Elsevier
Vascular calcification (VC) is highly prevalent in patients with chronic kidney disease (CKD)
and is strongly associated with cardiovascular mortality and morbidity. Accumulating …

Biomarkers of inflammation and cardiac remodeling: the quest of relevant companions for the risk stratification of heart failure patients is still ongoing

D Gruson, SA Ahn, MF Rousseau - Biochemia medica, 2011 - hrcak.srce.hr
Sažetak Heart failure (HF) is a frequent chronic disease in elderly people and represents a
major health and economic burden. The accurate diagnosis of HF and the identification of …

The role of OPG/RANKL in the pathogenesis of diabetic cardiovascular disease

H Forde, C Davenport, E Harper… - Cardiovascular …, 2018 - journals.lww.com
Cardiovascular (CV) disease is the leading cause of mortality in patients with type 2
diabetes mellitus. A major factor in the pathogenesis of CV disease is vascular calcification …